The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Servier
Speakers' Bureau - Bristol-Myers Squibb; Leo Pharma; Pierre Fabre; Roche; ROVI; Sanofi; SERVIER
Epidemiological biliary tract cancer characterization: A patient cohort from the Spanish RETUD registry.
 
Teresa Macarulla
Consulting or Advisory Role - Ability Pharma; Advance Medical; Aptitude Health; AstraZeneca; Basilea; Baxter; BioLineRX; Celgene; Eisai; Genzyme; Incyte; Ipsen; Lilly; Medscape; Menarini; MSD; Novocure; Paraxel; PPD; Prime Oncology; QED Therapeutics; Roche; Sanofi/Aventis; SERVIER; Swedish Orphan Biovitrum; Zymeworks
Research Funding - Agios (Inst); ASLAN Pharmaceuticals (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Genentech (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Merrimack (Inst); Millennium (Inst); Novartis (Inst); Novocure (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; H3 Biomedicine; Incyte; Merck; Prime Oncology; Sanofi; SERVIER
 
Maialen Barrero
No Relationships to Disclose
 
Jorge Adeva
No Relationships to Disclose
 
Oscar Alfredo Castillo Trujillo
No Relationships to Disclose
 
Andrés J. Muñoz Martín
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Pfizer; Celgene; Daiichi Sankyo; Incyte; LEO Pharma; Lilly; MSD Oncology; Roche; Sanofi
Speakers' Bureau - Bayer; Menarini; Rovi; SERVIER
Research Funding - Celgene; LEO Pharma; Sanofi
Patents, Royalties, Other Intellectual Property - Risk assessment model in venous thromboembolism in cancer patients
Travel, Accommodations, Expenses - Amgen; Celgene; Merck Serono; Roche
 
Paloma Peinado Martin
Speakers' Bureau - Lilly; Merck
 
Helena Verdaguer
Consulting or Advisory Role - Merck
Speakers' Bureau - AstraZeneca
 
Eva Martinez de Castro
No Relationships to Disclose
 
Miriam Lobo De Mena
Consulting or Advisory Role - Fresenius Kabi; Leo Pharma
Speakers' Bureau - Pfizer; SERVIER; Vifor Pharma
 
Mónica Granja
Consulting or Advisory Role - SERVIER
Speakers' Bureau - SERVIER
Travel, Accommodations, Expenses - Angelini Pharma; Merck; Roche; SERVIER
 
Rosa Rodríguez Alonso
Research Funding - IMIBIC (Inst)
 
Noelia Garcia Cid
No Relationships to Disclose
 
Elena Asensio-Martínez
Consulting or Advisory Role - Amgen; Roche; SERVIER
Speakers' Bureau - Amgen; Merck; Roche; SERVIER
 
Ruth Vera
Consulting or Advisory Role - Amgen; Merck; Roche
Speakers' Bureau - Abbott; Amgen; Bayer; Merck; Roche; Sanofi
 
Begoña Graña
No Relationships to Disclose
 
Ismael Ghanem
No Relationships to Disclose
 
Inmaculada Alés
No Relationships to Disclose
 
Raquel Molina
Consulting or Advisory Role - Lilly; Merck; Roche; Sanofi
Expert Testimony - Lilly; Merck; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Lilly; Merck; Roche; Sanofi
Other Relationship - Amgen; Lilly; Merck; Roche; Sanofi
 
Berta Laquente
No Relationships to Disclose
 
Enrique Aranda
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck; Roche; Sanofi